# Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)

> **NCT01911637** · PHASE1 · COMPLETED · sponsor: **Virobay Inc.** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** VBY-036
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01911637
- **Lead sponsor:** Virobay Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911637, "Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01911637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*